Source: Eur Respir J 2012; 40: 1344-1353
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Néstor Soler, Mariano Esperatti, Santiago Ewig, Arturo Huerta, Carlos Agustí, Antoni Torres. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J 2012; 40: 1344-1353

Member's Comments

No comment yet.

Related content which might interest you: Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Definition and aetiology of infective exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 58-67 Year: 2013 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248 Year: 2013 Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248-249 Year: 2013 Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis Source: Eur Respir J 2012; 39: 1354-1360 Year: 2012 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010